South Korea
South Korea OKs clinical trial of COVID-19 Plasma Therapy - Reports
Moscow/Sputnik: South Korea green-lighted on Thursday phase 2 of a clinical trial of COVID-19 plasma treatment by firm GC Pharma, Yonhap reported.
The Ministry of Food and Drug Safety has skipped phase one of the trial, as the therapy itself is well-known and considered to be safe.
Several hospitals will start administering the therapy to patients who would volunteer to accept the treatment.
In total, clinical trials for 14 coronavirus treatments and two vaccines are currently underway in South Korea, according to the news agency.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
